AVEO PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Aveo Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2022.
  • Aveo Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2022 was 34.6M shares, a 0.71% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 32.7M shares, a 52.6% increase from 2020.
  • Aveo Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 21.4M shares, a 39.6% increase from 2019.
  • Aveo Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2019 was 15.3M shares, a 27.1% increase from 2018.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 34.6M +244K +0.71% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 34.5M +141K +0.41% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 34.5M +7.05M +25.7% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 34.4M +8.13M +31% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-14
Q3 2021 34.4M +8.57M +33.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 34.4M +17M +97.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 27.4M +11.3M +70.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 26.3M +10.2M +63.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 25.8M +9.73M +60.6% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-14
Q2 2020 17.4M +1.46M +9.19% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-14
Q1 2020 16.1M +2.85M +21.6% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-14
Q4 2019 16.1M +3.64M +29.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 16.1M +4.06M +33.8% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-16
Q2 2019 15.9M +4.01M +33.7% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-16
Q1 2019 13.2M +1.35M +11.3% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-16
Q4 2018 12.4M -106M -89.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 12M -106M -89.8% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 11.9M -98.7M -89.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 11.9M -64.4M -84.4% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 118M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 118M +42.1M +55.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 111M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 76.2M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
Q3 2016 75.9M +19.1M +33.6% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-04
Q3 2015 56.8M +5.02M +9.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q3 2014 51.8M +328K +0.64% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 51.7M +351K +0.68% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-11
Q1 2014 51.6M +2.25M +4.57% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-07
Q4 2013 50.9M +7.55M +17.4% Oct 1, 2013 Dec 31, 2013 10-K 2014-03-13
Q3 2013 51.4M +8.01M +18.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 51.3M +7.99M +18.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 49.4M +6.13M +14.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 43.4M +3.66M +9.21% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-13
Q3 2012 43.4M +413K +0.96% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-08
Q2 2012 43.3M +6.47M +17.6% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-07
Q1 2012 43.3M +7.47M +20.9% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-09
Q4 2011 39.7M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 43M +12.1M +39.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 36.8M +6.03M +19.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 35.8M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 30.9M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 30.8M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.